Comparison of Dexamethasone and N Acetylcysteine (NAC) Versus N Acetylcysteine (NAC) Alone in the Prevention of Post Embolization Syndrome in Patients With Hepatocellular Carcinoma Following Transarterial Chemoembolization.
Condition: Hepatocellular Carcinoma Interventions: Drug: N Acetylcysteine; Drug: Dexamethasone; Other: Placebo Sponsor: Institute of Liver and Biliary Sciences, India Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acetylcysteine | Cancer & Oncology | Carcinoma | Dexamethasone | Hepatocellular Carcinoma | India Health | Liver Cancer | Research